ReP USP - Resultado da busca

Artigo de periodico
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection (2024)
Ricciardi, Michael J ; Rust, Lauren N ; Pedreno-lopez, Nuria ; Yusova, Sofiya ; Biswas, Sreya ; Webb, Gabriela M; Gonzalez-Nieto, Lucas ; Voigt, Thomas B ; Louw, Johan J ; Laurino, Fernanda D ; Kallas, Esper Georges
Fonte: Science translational medicine. Unidade: FM
Assuntos: VETORES, FEBRE AMARELA, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICCIARDI, Michael J et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, v. 15, n. 689, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53922. Acesso em: 05 jul. 2024.
APA
Ricciardi, M. J., Rust, L. N., Pedreno-lopez, N., Yusova, S., Biswas, S., Webb, G. M., et al. (2024). Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, 15( 689). doi:10.1126/scitranslmed.ade5795
NLM
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922
Vancouver
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922
Artigo de periodico
Viral Kinetics in Sylvatic Yellow Fever Cases (2023)
Silva, Vivian Helena Iida Avelino da ; Thomazella, Mateus Vailant ; Marmorato, Mariana Prado ; Correia, Carolina Argondizo ; Dias, Juliana Zanatta de Carvalho; Maestri, Alvino; Cerqueira, Natalia Barros; Moreira, Carlos Henrique Valente ; Buccheri, Renata ; Félix, Alvina Clara ; Zanella, Luiz Gonzaga Francisco de Assis Barros D'Elia ; Costa, Priscilla Ramos; Kallas, Esper Georges
Fonte: Journal of infectious diseases. Unidade: FM
Assuntos: CARGA VIRAL, FEBRE AMARELA, DOENÇAS INFECCIOSAS, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vivian Helena Iida Avelino da et al. Viral Kinetics in Sylvatic Yellow Fever Cases. Journal of infectious diseases, v. 227, n. 9, p. 1097-1103, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53927. Acesso em: 05 jul. 2024.
APA
Silva, V. H. I. A. da, Thomazella, M. V., Marmorato, M. P., Correia, C. A., Dias, J. Z. de C., Maestri, A., et al. (2023). Viral Kinetics in Sylvatic Yellow Fever Cases. Journal of infectious diseases, 227( 9), 1097-1103. doi:10.1093/infdis/jiac435
NLM
Silva VHIA da, Thomazella MV, Marmorato MP, Correia CA, Dias JZ de C, Maestri A, Cerqueira NB, Moreira CHV, Buccheri R, Félix AC, Zanella LGF de ABD'E, Costa PR, Kallas EG. Viral Kinetics in Sylvatic Yellow Fever Cases [Internet]. Journal of infectious diseases. 2023 ; 227( 9): 1097-1103.[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53927
Vancouver
Silva VHIA da, Thomazella MV, Marmorato MP, Correia CA, Dias JZ de C, Maestri A, Cerqueira NB, Moreira CHV, Buccheri R, Félix AC, Zanella LGF de ABD'E, Costa PR, Kallas EG. Viral Kinetics in Sylvatic Yellow Fever Cases [Internet]. Journal of infectious diseases. 2023 ; 227( 9): 1097-1103.[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53927
Artigo de periodico
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) (2023)
Bonifácio, Lívia Pimenta ; Ramacciotti, Eduardo ; Agati, Leandro Barile ; Vilar, Fernando Crivelenti; Silva, Anna Christina Tojal da; Louzada Junior, Paulo; Fonseca, Benedito Antonio Lopes da; Souza, Hayala Cristina Cavenague de; Oliveira, Caroline Candida Carvalho de; Aguiar, Valeria Cristina Resende; Kallas, Esper Georges ; Rodrigues, Fernando Bellíssimo
Fonte: Revista da sociedade brasileira de medicina tropical. Unidades: FMRP, FM
Assuntos: COVID-19, PACIENTES INTERNADOS, PANDEMIAS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFÁCIO, Lívia Pimenta et al. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, v. 56, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54695. Acesso em: 05 jul. 2024.
APA
Bonifácio, L. P., Ramacciotti, E., Agati, L. B., Vilar, F. C., Silva, A. C. T. da, Louzada Junior, P., et al. (2023). Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, 56. doi:10.1590/0037-8682-0565-2022
NLM
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Vancouver
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Artigo de periodico
Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls (2023)
Pereira-Manfro, Wania Ferraz; Silva, Giselle Pereira da; Costa, Priscilla Ramos; Costa, Dayane Alves; Ferreira, Bianca da Silva; Barreto, Daniela Mena; Frota, Ana Cristina Cisne; Hofer, Cristina Barroso; Kallas, Esper Georges ; Milagres, Lucimar Goncalves
Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: HIV, INFECÇÕES POR HIV, BIOMARCADORES, CRIANÇAS, ADOLESCENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MANFRO, Wania Ferraz et al. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls. Revista do instituto de medicina tropical de sao paulo, v. 65, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52957. Acesso em: 05 jul. 2024.
APA
Pereira-Manfro, W. F., Silva, G. P. da, Costa, P. R., Costa, D. A., Ferreira, B. da S., Barreto, D. M., et al. (2023). Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls. Revista do instituto de medicina tropical de sao paulo, 65. doi:10.1590/S1678-9946202365014
NLM
Pereira-Manfro WF, Silva GP da, Costa PR, Costa DA, Ferreira B da S, Barreto DM, Frota ACC, Hofer CB, Kallas EG, Milagres LG. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52957
Vancouver
Pereira-Manfro WF, Silva GP da, Costa PR, Costa DA, Ferreira B da S, Barreto DM, Frota ACC, Hofer CB, Kallas EG, Milagres LG. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52957
Artigo de periodico
Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors (2023)
Gil, Saulo ; Gualano, Bruno ; Araújo, Adriana Ladeira de; Oliveira Junior, Gersiel Nascimento de ; Damiano, Rodolfo Furlan ; Pinna, Fabio de Rezende ; Imamura, Marta ; Rocha, Vanderson ; Kallas, Esper Georges ; Batistella, Linamara Rizzo; Forlenza, Orestes Vicente ; Carvalho, Carlos Roberto Ribeiro De ; Busatto Filho, Geraldo ; Roschel, Hamilton ; HCFMUSP COVID-19 Study Group
Fonte: Scientific Reports. Unidades: FM, EEFE
Assuntos: COVID-19, SEDENTARISMO, QUALIDADE DE VIDA, PROGNÓSTICO, ATIVIDADE FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL, Saulo et al. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Scientific Reports, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-26888-3. Acesso em: 05 jul. 2024.
APA
Gil, S., Gualano, B., Araújo, A. L. de, Oliveira Junior, G. N. de, Damiano, R. F., Pinna, F. de R., et al. (2023). Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Scientific Reports, 13. doi:10.1038/s41598-022-26888-3
NLM
Gil S, Gualano B, Araújo AL de, Oliveira Junior GN de, Damiano RF, Pinna F de R, Imamura M, Rocha V, Kallas EG, Batistella LR, Forlenza OV, Carvalho CRRD, Busatto Filho G, Roschel H, HCFMUSP COVID-19 Study Group. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors [Internet]. Scientific Reports. 2023 ; 13[citado 2024 jul. 05 ] Available from: https://doi.org/10.1038/s41598-022-26888-3
Vancouver
Gil S, Gualano B, Araújo AL de, Oliveira Junior GN de, Damiano RF, Pinna F de R, Imamura M, Rocha V, Kallas EG, Batistella LR, Forlenza OV, Carvalho CRRD, Busatto Filho G, Roschel H, HCFMUSP COVID-19 Study Group. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors [Internet]. Scientific Reports. 2023 ; 13[citado 2024 jul. 05 ] Available from: https://doi.org/10.1038/s41598-022-26888-3
Artigo de periodico
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil (2022)
Petruccelli, Karla Cristina Silva; Baia-da-Silva, Djane Clarys; Val, Fernando; Valoes, Monica Santos; Cubas-Vega, Nadia; Silva-Neto, Alexandre Vilhena; Sampaio, Vanderson; Alencar, Aline; Pecoits-Filho, Roberto; Moreira, Rodrigo Carvalho; Kallas, Esper Georges
Fonte: Aids research and therapy. Unidade: FM
Assuntos: SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, ESTUDOS MULTICÊNTRICOS, TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRUCCELLI, Karla Cristina Silva et al. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. Aids research and therapy, v. 19, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12981-022-00437-4. Acesso em: 05 jul. 2024.
APA
Petruccelli, K. C. S., Baia-da-Silva, D. C., Val, F., Valoes, M. S., Cubas-Vega, N., Silva-Neto, A. V., et al. (2022). Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. Aids research and therapy, 19( 1). doi:10.1186/s12981-022-00437-4
NLM
Petruccelli KCS, Baia-da-Silva DC, Val F, Valoes MS, Cubas-Vega N, Silva-Neto AV, Sampaio V, Alencar A, Pecoits-Filho R, Moreira RC, Kallas EG. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 jul. 05 ] Available from: https://doi.org/10.1186/s12981-022-00437-4
Vancouver
Petruccelli KCS, Baia-da-Silva DC, Val F, Valoes MS, Cubas-Vega N, Silva-Neto AV, Sampaio V, Alencar A, Pecoits-Filho R, Moreira RC, Kallas EG. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 jul. 05 ] Available from: https://doi.org/10.1186/s12981-022-00437-4
Artigo de periodico
Humoral and cellular immune responses to CoronaVac up to one year after vaccination (2022)
Costa, Priscilla Ramos; Correia, Carolina Argondizo; Marmorato, Mariana Prado; Dias, Juliana Zanatta de Carvalho; Thomazella, Mateus Vailant; Silva, Amanda Cabral da; Oliveira, Ana Carolina Soares de; Gusmao, Arianne Fagotti; Ferrari, Lilian; Freitas, Angela Carvalho; Kallas, Esper Georges
Fonte: Frontiers in immunology. Unidade: FM
Assuntos: COVID-19, VACINAS VIRAIS, SISTEMA IMUNE, CITOCINAS, ANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Priscilla Ramos et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50534. Acesso em: 05 jul. 2024.
APA
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. de C., Thomazella, M. V., Silva, A. C. da, et al. (2022). Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.1032411
NLM
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Vancouver
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Artigo de periodico
Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers (2022)
Luna-Muschi, Alessandra; Borges, Igor C; Faria, Elizabeth de; Barboza, Antonio S; Maia, Fernando L; Leme, Mariana D; Guedes, Ana Rubia; Correa, Maria Cássia Jacintho Mendes ; Kallas, Esper Georges ; Segurado, Aluisio Augusto Cotrim ; Sabino, Ester Cerdeira ; Levin, Anna Sara Shafferman ; Costa, Sílvia Figueiredo
Fonte: Journal of infection. Unidades: FM, RUSP
Assuntos: ARTIGOS DE PERIÓDICOS, VACINAÇÃO, COVID-19, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNA-MUSCHI, Alessandra et al. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, v. 84, n. 2, p. 262-265, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jinf.2021.09.005. Acesso em: 05 jul. 2024.
APA
Luna-Muschi, A., Borges, I. C., Faria, E. de, Barboza, A. S., Maia, F. L., Leme, M. D., et al. (2022). Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, 84( 2), 262-265. doi:10.1016/j.jinf.2021.09.005
NLM
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Vancouver
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Artigo de periodico
Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus (2022)
Yuki, Emily F. N; Borba Neto, Eduardo Ferreira ; Pasoto, Sandra G; Seguro, Luciana P; Lopes, Michelle; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Arthritis care & research. Unidade: FM
Assuntos: ANTICORPOS, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKI, Emily F. N et al. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, v. 74, n. 4, p. 562-571, 2022Tradução . . Disponível em: https://doi.org/10.1002/acr.24824. Acesso em: 05 jul. 2024.
APA
Yuki, E. F. N., Borba Neto, E. F., Pasoto, S. G., Seguro, L. P., Lopes, M., Saad, C. G. S., et al. (2022). Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, 74( 4), 562-571. doi:10.1002/acr.24824
NLM
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1002/acr.24824
Vancouver
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1002/acr.24824
Artigo de periodico
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
Medeiros-Ribeiro, Ana Cristina; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Silva, Henrique Carrico da; Saad, Carla G. S.; Yuki, Emily Figueiredo Neves; Pasoto, Sandra Gofinet; Araujo, Carlo Scognamiglio Renner; Nakai, Tatiane Lie; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Annals of the rheumatic diseases. Unidade: FM
Assuntos: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 05 jul. 2024.
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Artigo de periodico
Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis (2022)
Correa, Frederico J. S; Andres, Marina Paula; Rocha, Taina Pezzin; Carvalho, Ana Eduarda Z; Aloia, Thiago P. A; Corpa, Marcus V. N; Kallas, Esper Georges ; Mangueira, Cristovao L. P; Baracat, Edmund Chada ; I, Karina Carvalho; Abrão, Maurício Simões
Fonte: Clinics. Unidade: FM
Assuntos: ENDOMETRIOSE, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORREA, Frederico J. S et al. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics, v. 77, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2022.100032. Acesso em: 05 jul. 2024.
APA
Correa, F. J. S., Andres, M. P., Rocha, T. P., Carvalho, A. E. Z., Aloia, T. P. A., Corpa, M. V. N., et al. (2022). Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics, 77. doi:10.1016/j.clinsp.2022.100032
NLM
Correa FJS, Andres MP, Rocha TP, Carvalho AEZ, Aloia TPA, Corpa MVN, Kallas EG, Mangueira CLP, Baracat EC, I KC, Abrão MS. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis [Internet]. Clinics. 2022 ; 77[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100032
Vancouver
Correa FJS, Andres MP, Rocha TP, Carvalho AEZ, Aloia TPA, Corpa MVN, Kallas EG, Mangueira CLP, Baracat EC, I KC, Abrão MS. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis [Internet]. Clinics. 2022 ; 77[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100032
Artigo de periodico
Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction (2022)
Oliveira, Beatriz Araujo; Oliveira, Lea Campos de; Oliveira, Franciane Mendes de; Pereira, Geovana Maria ; Souza, Regina Maia de; Manuli, Erika Regina ; Marchini, Fabricio Klerynton; Espinoza, Evelyn Patricia Sanchez; Park, Marcelo ; Taniguchi, Leandro Utino ; Kallas, Esper Georges ; Levin, Anna Sara Shafferman ; Sabino, Ester Cerdeira ; Costa, Sílvia Figueiredo
Fonte: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Assuntos: COVID-19, ENSAIOS QUÍMICOS, IMUNOHISTOQUÍMICA, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Beatriz Araujo et al. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50558. Acesso em: 05 jul. 2024.
APA
Oliveira, B. A., Oliveira, L. C. de, Oliveira, F. M. de, Pereira, G. M., Souza, R. M. de, Manuli, E. R., et al. (2022). Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264063
NLM
Oliveira BA, Oliveira LC de, Oliveira FM de, Pereira GM, Souza RM de, Manuli ER, Marchini FK, Espinoza EPS, Park M, Taniguchi LU, Kallas EG, Levin ASS, Sabino EC, Costa SF. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50558
Vancouver
Oliveira BA, Oliveira LC de, Oliveira FM de, Pereira GM, Souza RM de, Manuli ER, Marchini FK, Espinoza EPS, Park M, Taniguchi LU, Kallas EG, Levin ASS, Sabino EC, Costa SF. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50558
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Fonte: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Assuntos: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 05 jul. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Artigo de periodico
Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort (2022)
Silveira, Cassia G. T.; Magnani, Diogo M.; Costa, Priscilla R.; Silva, Vivian Helena Iida Avelino da ; Ricciardi, Michael J.; Timenetsky, Maria do Carmo S. T.; Goulart, Raphaella; Correia, Carolina A.; Marmorato, Mariana P.; Ferrari, Lilian; Kalil Filho, Jorge Elias ; Kallas, Esper Georges
Fonte: Frontiers in immunology. Unidade: FM
Assuntos: VACINAS VIRAIS, ADULTOS, INFLUENZA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Cassia G. T. et al. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.908398. Acesso em: 05 jul. 2024.
APA
Silveira, C. G. T., Magnani, D. M., Costa, P. R., Silva, V. H. I. A. da, Ricciardi, M. J., Timenetsky, M. do C. S. T., et al. (2022). Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.908398
NLM
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jul. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.908398
Vancouver
Silveira CGT, Magnani DM, Costa PR, Silva VHIA da, Ricciardi MJ, Timenetsky M do CST, Goulart R, Correia CA, Marmorato MP, Ferrari L, Kalil Filho JE, Kallas EG. Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naive and DENV-Exposed Individuals in a Brazilian Cohort [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 jul. 05 ] Available from: https://doi.org/10.3389/fimmu.2022.908398
Artigo de periodico
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy (2022)
Looby, Sara E.; Kantor, Amy; Burdo, Tricia H.; Currier, Judith S.; Fichtenbaum, Carl J.; Overton, Edgar T.; Aberg, Judith A.; Malvestutto, Carlos D.; Bloomfield, Gerald S.; Erlandson, Kristine M.; Kallas, Esper Georges
Fonte: Clinical infectious diseases. Unidade: FM
Assuntos: TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE, HIV, MORTALIDADE, FATORES DE RISCO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOOBY, Sara E. et al. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clinical infectious diseases, v. 75, n. 8, p. 1324-1333, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50552. Acesso em: 05 jul. 2024.
APA
Looby, S. E., Kantor, A., Burdo, T. H., Currier, J. S., Fichtenbaum, C. J., Overton, E. T., et al. (2022). Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clinical infectious diseases, 75( 8), 1324-1333. doi:10.1093/cid/ciac166
NLM
Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Kallas EG. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy [Internet]. Clinical infectious diseases. 2022 ; 75( 8): 1324-1333.[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50552
Vancouver
Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Kallas EG. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy [Internet]. Clinical infectious diseases. 2022 ; 75( 8): 1324-1333.[citado 2024 jul. 05 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50552
Artigo de periodico
Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome (2022)
Ferreira, Juliana Carvalho; Moreira, Tiana Carla Lopes ; Araújo, Adriana Ladeira de; Imamura, Marta ; Damiano, Rodolfo Furlan ; Garcia, Michelle L; Sawamura, Marcio Valente Yamada ; Pinna, Fabio de Rezende ; Guedes, Bruno Fukelmann ; Gonçalves, Fabio Augusto Rodrigues ; Mancini, Marcio ; Burdmann, Emmanuel de Almeida ; Silva Filho, Demóstenes Ferreira da ; Polizel, Jefferson Lordello ; Bento, Ricardo Ferreira ; Rocha, Vanderson ; Nitrini, Ricardo ; Souza, Heraldo Possolo de ; Levin, Anna Sara Shafferman ; Kallas, Esper Georges ; Forlenza, Orestes Vicente ; Busatto Filho, Geraldo ; Batistella, Linamara Rizzo; Carvalho, Carlos Roberto Ribeiro de; Mauad, Thais ; Gouveia, Nelson
Fonte: Journal of Global Health. Unidades: FM, ESALQ
Assuntos: COVID-19, CORONAVIRUS, REABILITAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Juliana Carvalho et al. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. Journal of Global Health, v. 12, p. 1-12, 2022Tradução . . Disponível em: https://doi.org/10.7189/jogh.12.05029. Acesso em: 05 jul. 2024.
APA
Ferreira, J. C., Moreira, T. C. L., Araújo, A. L. de, Imamura, M., Damiano, R. F., Garcia, M. L., et al. (2022). Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome. Journal of Global Health, 12, 1-12. doi:10.7189/jogh.12.05029
NLM
Ferreira JC, Moreira TCL, Araújo AL de, Imamura M, Damiano RF, Garcia ML, Sawamura MVY, Pinna F de R, Guedes BF, Gonçalves FAR, Mancini M, Burdmann E de A, Silva Filho DF da, Polizel JL, Bento RF, Rocha V, Nitrini R, Souza HP de, Levin ASS, Kallas EG, Forlenza OV, Busatto Filho G, Batistella LR, Carvalho CRR de, Mauad T, Gouveia N. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome [Internet]. Journal of Global Health. 2022 ; 12 1-12.[citado 2024 jul. 05 ] Available from: https://doi.org/10.7189/jogh.12.05029
Vancouver
Ferreira JC, Moreira TCL, Araújo AL de, Imamura M, Damiano RF, Garcia ML, Sawamura MVY, Pinna F de R, Guedes BF, Gonçalves FAR, Mancini M, Burdmann E de A, Silva Filho DF da, Polizel JL, Bento RF, Rocha V, Nitrini R, Souza HP de, Levin ASS, Kallas EG, Forlenza OV, Busatto Filho G, Batistella LR, Carvalho CRR de, Mauad T, Gouveia N. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome [Internet]. Journal of Global Health. 2022 ; 12 1-12.[citado 2024 jul. 05 ] Available from: https://doi.org/10.7189/jogh.12.05029
Artigo de periodico
The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts (2022)
Averhoff, Francisco; Berg, Michael; Rodgers, Mary; Osmanov, Saladin; Luo, Xinxin; Anderson, Mark; Meyer, Todd; Landay, Alan; Gamkrelidze, Amiran; Kallas, Esper Georges
Fonte: International journal of infectious diseases. Unidade: FM
Assuntos: VIGILÂNCIA DA POPULAÇÃO, PANDEMIAS, SAÚDE PÚBLICA, VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AVERHOFF, Francisco et al. The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts. International journal of infectious diseases, v. 117, p. 356-360, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2022.02.001. Acesso em: 05 jul. 2024.
APA
Averhoff, F., Berg, M., Rodgers, M., Osmanov, S., Luo, X., Anderson, M., et al. (2022). The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts. International journal of infectious diseases, 117, 356-360. doi:10.1016/j.ijid.2022.02.001
NLM
Averhoff F, Berg M, Rodgers M, Osmanov S, Luo X, Anderson M, Meyer T, Landay A, Gamkrelidze A, Kallas EG. The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts [Internet]. International journal of infectious diseases. 2022 ; 117 356-360.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.ijid.2022.02.001
Vancouver
Averhoff F, Berg M, Rodgers M, Osmanov S, Luo X, Anderson M, Meyer T, Landay A, Gamkrelidze A, Kallas EG. The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness efforts [Internet]. International journal of infectious diseases. 2022 ; 117 356-360.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.ijid.2022.02.001
Artigo de periodico
Article Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies (2022)
Haslwanter, Denise; Lasso, Gorka; Wec, Anna Z.; Furtado, Nathalia Dias; Raphael, Lidiane Menezes Souza; Tse, Alexandra L.; Sun, Yan; Stransky, Stephanie; Pedreno-lopez, Nuria; Correia, Carolina Argondizo; Kallas, Esper Georges
Fonte: Cell host & microbe. Unidade: FM
Assuntos: SUL-AMERICANOS, GENÓTIPOS, FEBRE AMARELA, PREDISPOSIÇÃO GENÉTICA PARA DOENÇA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HASLWANTER, Denise et al. Article Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies. Cell host & microbe, v. 30, n. 2, p. 248-+, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.chom.2021.12.009. Acesso em: 05 jul. 2024.
APA
Haslwanter, D., Lasso, G., Wec, A. Z., Furtado, N. D., Raphael, L. M. S., Tse, A. L., et al. (2022). Article Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies. Cell host & microbe, 30( 2), 248-+. doi:10.1016/j.chom.2021.12.009
NLM
Haslwanter D, Lasso G, Wec AZ, Furtado ND, Raphael LMS, Tse AL, Sun Y, Stransky S, Pedreno-lopez N, Correia CA, Kallas EG. Article Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies [Internet]. Cell host & microbe. 2022 ; 30( 2): 248-+.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.chom.2021.12.009
Vancouver
Haslwanter D, Lasso G, Wec AZ, Furtado ND, Raphael LMS, Tse AL, Sun Y, Stransky S, Pedreno-lopez N, Correia CA, Kallas EG. Article Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodies [Internet]. Cell host & microbe. 2022 ; 30( 2): 248-+.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/j.chom.2021.12.009
Artigo de periodico
Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records (2022)
Rodrigues, Davi Silva ; Nastri, Ana Catharina de Seixas Santos ; Magri, Marcello M.; Oliveira, Maura Salaroli de ; Sabino, Ester Cerdeira ; Figueiredo, Pedro H. M. F.; Levin, Anna Sara ; Freire, Maristela P. ; Harima, Leila; Nunes, Fátima L. S.; Ferreira, João Eduardo ; Busatto, Geraldo ; Bonfa, Eloisa Silva Dutra de Oliveira ; Utiyama, Edivaldo Massazo ; Segurado, Aluisio Augusto Cotrim ; Perondi, Beatriz ; Morais, Anna M.; Montal, Amanda ; Fusco, Solange ; Fregonesi, Marjorie; Rocha, Marcelo; Marcílio, Izabel ; Rios, Izabel C; Kawano, Fabiane Y. O.; de Jesus, M. Amelia; Kallas, Esper Georges ; Marmo, Carolina; Tanaka, Clarice ; Souza, Heraldo Possolo de ; Marchini, Julio Flavio ; Carvalho, Carlos; Ferreira, Juliana C.; Guimarães, Thais ; Lazari, Carolina S.; Duarte, Alberto José da Silva; Francisco, M. Cristina P. B.; Costa, Sílvia Figueiredo
Fonte: BMC Medical Informatics and Decision Making. Unidades: FM, EACH, IME, FMRP
Assuntos: COVID-19, SINAIS VITAIS, ANÁLISE DE SÉRIES TEMPORAIS, COMPUTAÇÃO APLICADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Davi Silva et al. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, v. 22, n. artigo 187, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12911-022-01931-5. Acesso em: 05 jul. 2024.
APA
Rodrigues, D. S., Nastri, A. C. de S. S., Magri, M. M., Oliveira, M. S. de, Sabino, E. C., Figueiredo, P. H. M. F., et al. (2022). Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records. BMC Medical Informatics and Decision Making, 22( artigo 187). doi:10.1186/s12911-022-01931-5
NLM
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 jul. 05 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Vancouver
Rodrigues DS, Nastri AC de SS, Magri MM, Oliveira MS de, Sabino EC, Figueiredo PHMF, Levin AS, Freire MP, Harima L, Nunes FLS, Ferreira JE, Busatto G, Bonfa ESD de O, Utiyama EM, Segurado AAC, Perondi B, Morais AM, Montal A, Fusco S, Fregonesi M, Rocha M, Marcílio I, Rios IC, Kawano FYO, de Jesus MA, Kallas EG, Marmo C, Tanaka C, Souza HP de, Marchini JF, Carvalho C, Ferreira JC, Guimarães T, Lazari CS, Duarte AJ da S, Francisco MCPB, Costa SF. Predicting the outcome for COVID-19 patients by applying time series classification to electronic health records [Internet]. BMC Medical Informatics and Decision Making. 2022 ; 22( artigo 187):[citado 2024 jul. 05 ] Available from: https://doi.org/10.1186/s12911-022-01931-5
Artigo de periodico
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study (2022)
Aikawa, Nadia E; Kupa, Leonard de Vinci Kanda ; Pasoto, Sandra Gofinet; Shinjo, Samuel Katsuyuki ; Pereira, Rosa Maria Rodrigues ; Sartori, Ana Marli Christovam ; Duarte, Alberto José da Silva; Antonangelo, Leila ; Sabino, Ester Cerdeira ; Menezes, Paulo Rossi ; Kallas, Esper Georges ; Silva, Clovis Artur Almeida da ; Bonfa, Eloisa Silva Dutra de Oliveira
Fonte: Lancet rheumatology. Unidade: FM
Assuntos: IMUNOGENÉTICA, COVID-19, SISTEMA IMUNE, IMUNOGENICIDADE DA VACINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia E et al. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, v. 4, n. 2, p. E113-E124, 2022Tradução . . Disponível em: https://doi.org/10.1016/S2665-9913(21)00327-1. Acesso em: 05 jul. 2024.
APA
Aikawa, N. E., Kupa, L. de V. K., Pasoto, S. G., Shinjo, S. K., Pereira, R. M. R., Sartori, A. M. C., et al. (2022). Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study. Lancet rheumatology, 4( 2), E113-E124. doi:10.1016/S2665-9913(21)00327-1
NLM
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1
Vancouver
Aikawa NE, Kupa L de VK, Pasoto SG, Shinjo SK, Pereira RMR, Sartori AMC, Duarte AJ da S, Antonangelo L, Sabino EC, Menezes PR, Kallas EG, Silva CAA da, Bonfa ESD de O. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study [Internet]. Lancet rheumatology. 2022 ; 4( 2): E113-E124.[citado 2024 jul. 05 ] Available from: https://doi.org/10.1016/S2665-9913(21)00327-1

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos